COSMETICS · SERVICE DETAILS

Cosmetics product listing

Assists the responsible persons in sorting out the information required for the product type, composition and product listing.

Applicability and scope depend on the product, your business role and the agreed engagement. The service does not constitute FDA approval or certification.

SERVICE OVERVIEW

What does this service help with?

To assist the respective duty-bearers in compiling the information required for product categories, components and product listing, we will first identify the specific matters to be addressed and the scope of collaboration, taking into account product categories and the applicability of current information.

WHO MAY NEED IT

Who should consider this service?

Foreign manufacturers, branders and related responsible persons who plan to sell cosmetics in the United States still need to be identified on a case-by-case basis in relation to the type of product, business activity, target markets and applicable legislation.

SCOPE & APPROACH

What we typically discuss

Identify information gaps before agreeing on documentation and responsibilities.

01

Confirm the product and business entity

Review product characteristics, responsible businesses and facilities, activities and existing records to select the appropriate process.

02

Review applicable requirements

Confirm requirements and open questions about registration, listing, documentation, labels or contact information relevant to the service.

03

Agree on the specific scope

Discuss required documents, responsibilities, timing and fees. The agreed scope governs the work.

GET READY

What to prepare before contacting us

If documents are incomplete, share the product and current stage first. You can provide the remaining details later.

  • Product use, composition, mode of use and declaration
  • Information on facilities and responsible persons, brands and products
  • Existing registration/listing records and product labels
HOW TO START

From initial review to engagement

STEP 01

Describe your current needs

Share the product, your role, target market and current stage.

STEP 02

Provide additional materials

Prepare relevant facility, product, technical or label records based on the service.

STEP 03

Confirm service arrangements

Define the applicable requirements, scope, documentation responsibilities and fees.

STEP 04

Proceed with the agreed work

Work within the confirmed scope and discuss applicable maintenance.

Registration, listing or submission of supporting information does not confer FDA approval, certification or marketing authorization. Refer to current FDA requirements and the facts of your project.

TIMING & FEES

Timing and fees

Information reviewed:Fee period: FDA rules checked November 5, 2026. Verify charges for the applicable date or fiscal year.

Timing and preparation

Document preparation

The agreed delivery plan is available and the scope is confirmed; The volume of products, technical information gaps, changing wheels and the speed of client feedback affect the lead time.

FDA processing

(c) Producting Listing is done at the applicable time point on the market and is updated annually as required; Processing time to be influenced by formulations, label dutyrs, facility information and system verification.

Fee breakdown

FDA fees

FDA does not charge the cost of filing for the registration of the facility or the product listing under article 607 of MoCRA; Third-party services such as Chargé d ' affaires, agents, security support, testing, etc. are separately accounted for.

Service fees

Consulting and filing are quoted separately from FDA fees, based on the number of products, completeness of the records, work scope, response rounds and service term.

Other possible costs

Testing, translation, software and other third-party work are quoted separately where needed.

START WITH YOUR PRODUCT

Tell us about your product so we can discuss the appropriate pathway.

Share intended use, ingredients or technical characteristics, production location, business role and current stage. We can use this information to discuss likely FDA requirements and service scope.